menu
    • menu

    Company profile for CinnaGen

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    With Virupaksha, you get a quality product with on-time delivery.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    ChemExpress delivers end-to-end CRO & CDMO solutions for small molecules, biologics & new modalities with ICH-grade quality.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    CinnaGen was founded in 1994 with the goal of manufacturing hi-tech products in biotechnology. Production activities are performed in our 11,000m2 area with over 6,000 m2area clean rooms. We are committed to quality assurance and regulatory affairs and absolute practice of cGMP. The company provides a one-stop shop solution from API to finish product formulation.Biopharmaceutical grade APIs : re-Hu PTH, re-Hu FSH, re-Hu GCSF&P...
    CinnaGen was founded in 1994 with the goal of manufacturing hi-tech products in biotechnology. Production activities are performed in our 11,000m2 area with over 6,000 m2area clean rooms. We are committed to quality assurance and regulatory affairs and absolute practice of cGMP. The company provides a one-stop shop solution from API to finish product formulation.Biopharmaceutical grade APIs : re-Hu PTH, re-Hu FSH, re-Hu GCSF&PEG-GCSF, re-Hu Growth Hormone, re-Hu Erythropoietin , Buserelin.Finish products: CinnoVex (Interferon Beta-1a, 30µg) , ReciGen (Interferon Beta-1a, 44µg), CinnoPar (Teriparatide), Cinnal-f (Follitropin Alfa), etc.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    CinnaGenIran Flag
    Country
    Country
    Iran
    Address
    Address
    No.2 , 7thSt., Simaye Iran St., Shahrak Gharb, Tehran
    Telephone
    Telephone
    +98 21 42815
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://cinnagen.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/cinnagen/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/CinnaGen

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    CinnaGen protein subunit Covid-19 vaccine Ph III results
    CinnaGen protein subunit Covid-19 vaccine Ph III results

    16 Sep 2021

    // Reynald Castaneda CLINICALTRIALSARENA

    https://www.clinicaltrialsarena.com/news/spikogen-vaccine-trial-results/

    Reynald Castaneda CLINICALTRIALSARENA
    16 Sep 2021
    Share Share
    Iranian drugmaker opens $100M plant in Turkey, will make Humira biosimilar
    Iranian drugmaker opens $100M plant in Turkey, will make Humira biosimilar

    13 Jun 2019

    // Eric Palmer FIERCE PHARMA

    https://www.fiercepharma.com/manufacturing/iranian-drugmaker-opens-100m-plant-turkey-will-make-humira-biosimilar

    Eric Palmer FIERCE PHARMA
    13 Jun 2019
    Share Share
    First MENA MAb manufacturer gets EMA GMP certificate
    First MENA MAb manufacturer gets EMA GMP certificate

    03 Sep 2018

    // PHARMA LETTER

    https://www.thepharmaletter.com/article/first-mena-mab-manufacturer-gets-ema-gmp-certificate

    PHARMA LETTER
    03 Sep 2018
    Share Share
    CinnaGen in new signal of intent to target EU biosimilars market
    CinnaGen in new signal of intent to target EU biosimilars market

    10 Aug 2018

    // PHARMA LETTER

    https://www.thepharmaletter.com/article/cinnagen-in-new-signal-of-intent-to-target-eu-biosimilars-market

    PHARMA LETTER
    10 Aug 2018
    Share Share
    CinnaGen CEO not holding back in ambition to be a global player
    CinnaGen CEO not holding back in ambition to be a global player

    15 Jul 2018

    // Guy Martin THEPHARMALETTER

    https://www.thepharmaletter.com/article/cinnagen-ceo-not-holding-back-in-ambition-to-be-a-global-player

    Guy Martin THEPHARMALETTER
    15 Jul 2018
    Share Share

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search